MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker

被引：1
|
作者：
Shimabukuro, Michio [1 ,2 ]
机构：
[1] Fukushima Med Univ, Dept Diabet Endocrinol & Metab, Fukushima, Japan
[2] Fukushima Med Univ, Dept Diabet Endocrinol & Metab, 1 Hikarigaoka, Fukushima 9601295, Japan
来源：
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 2023年 / 30卷 / 08期
关键词：
CARDIOVASCULAR RISK; DISEASE;
D O I：
10.5551/jat.ED227
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：853 / 854
页数：2
相关论文
共 50 条
  • [21] Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics
    Shang, Xiaofei
    Yuan, Huixin
    Dai, Lixia
    Liu, Yang
    He, Jian
    Chen, Huan
    Li, Hongyan
    Li, Xiuhui
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [22] The mechanism research on the anti-liver fibrosis of emodin based on network pharmacology
    Liang, Baoyu
    Gao, Liyuan
    Wang, Feixia
    Li, Zhanghao
    Li, Yujia
    Tan, Shanzhong
    Chen, Anping
    Shao, Jiangjuan
    Zhang, Zili
    Sun, Lixia
    Zhang, Feng
    Zheng, Shizhong
    IUBMB LIFE, 2021, 73 (09) : 1166 - 1179
  • [23] High plasma heparin cofactor II activity protects from restenosis, after femoropopliteal stenting
    Schillinger, M
    Exner, M
    Sabeti, S
    Mlekusch, W
    Amighi, J
    Handler, S
    Quehenberger, P
    Kalifeh, N
    Wagner, O
    Minar, E
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (05) : 1108 - 1113
  • [24] PURIFICATION OF HEPARIN COFACTOR-II FROM HUMAN PLASMA
    TOULON, P
    CHADEUF, G
    AIACH, M
    JOURNAL OF CHROMATOGRAPHY, 1991, 539 (02): : 493 - 500
  • [25] RETRACTION: Structural characterization and anti-liver cancer activity of a Cu(II)-based coordination polymer
    Dong, Yuan
    Yue, Li-Jun
    Dong, Zhi-Qiang
    Liu, Xiao-Meng
    INORGANIC AND NANO-METAL CHEMISTRY, 2023, 53 (09) : 1036 - 1036
  • [26] HEPARIN COFACTOR-II ACTIVITY IN PLASMA DURING PREGNANCY AND ORAL-CONTRACEPTIVE USE
    MASSOUH, M
    JATOI, A
    GORDON, EM
    RATNOFF, OD
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1989, 114 (06): : 697 - 699
  • [27] Plasma heparin cofactor II activity is a predictor of cardiovascular risk in patients with coronary heart disease
    Takamori, N
    Akaike, M
    Aihara, KI
    Hirono, A
    Yamaguchi, H
    Azuma, H
    Tamura, K
    Matsumoto, T
    CIRCULATION, 2005, 112 (17) : U754 - U754
  • [28] Synthesis and Anti-Liver Cancer Activity of a Novel Heterocycles Compound
    Jia, Ming-Guang
    Gao, Lei
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (08): : 1675 - 1679
  • [29] Fibrinogen modulates heparin cofactor II (HCII) antithrombin activity
    Rossi, E
    Duboscq, C
    Kordich, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 138 - 138
  • [30] Parching process of Schisandra chinensis improving its efficacy of anti-liver fibrosis
    Chiang, W. C.
    Wu, C. C.
    Tang, W. C.
    PLANTA MEDICA, 2014, 80 (10) : 836 - 836
12345